Literature DB >> 1432421

Hyperammonemia-hyperornithinemia-homocitrullinuria syndrome: neurologic, ophthalmologic, and neuropsychologic examination of six patients.

J F Lemay1, M A Lambert, G A Mitchell, M Vanasse, D Valle, J F Arbour, J Dubé, J Flessas, M Laberge, L Lafleur.   

Abstract

We report the clinical, electrophysiologic, ophthalmologic, and neuropsychologic features of six patients with hyperammonemia-hyperornithinemia-homocitrullinuria syndrome, an inborn error of ornithine metabolism. Pyramidal signs, decreased vibration sense, bucco-facio-lingual dyspraxia, and learning difficulties or subnormal intelligence were found in the majority. Anomalies of peripheral nerve conduction velocity and of evoked potentials were common, and one patient had markedly abnormal white matter images on cranial magnetic resonance imaging. One patient had retinal depigmentation and chorioretinal thinning. The clinical severity varied greatly among patients; in general, the three younger patients had less neurologic and intellectual impairment than did the three older patients. Only two of our patients have had episodes of symptomatic hyperammonemia. We conclude that hyperammonemia-hyperornithinemia-homocitrullinuria syndrome can be associated with widespread manifestations in the central and peripheral nervous systems. Although the control of hyperammonemia is an essential element in the treatment of these patients, the relationship of hyperammonemia to the chronic neuropsychologic problems of these patients is unclear.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1432421     DOI: 10.1016/s0022-3476(05)81900-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Ornithine and Homocitrulline Impair Mitochondrial Function, Decrease Antioxidant Defenses and Induce Cell Death in Menadione-Stressed Rat Cortical Astrocytes: Potential Mechanisms of Neurological Dysfunction in HHH Syndrome.

Authors:  Ângela Zanatta; Marília Danyelle Nunes Rodrigues; Alexandre Umpierrez Amaral; Débora Guerini Souza; André Quincozes-Santos; Moacir Wajner
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

2.  Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan.

Authors:  AbdulRazaq A H Sokoro; Joyce Lepage; Nick Antonishyn; Ryan McDonald; Cheryl Rockman-Greenberg; James Irvine; Denis C Lehotay
Journal:  J Inherit Metab Dis       Date:  2010-06-24       Impact factor: 4.982

Review 3.  The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

Authors:  Diego Martinelli; Daria Diodato; Emanuela Ponzi; Magnus Monné; Sara Boenzi; Enrico Bertini; Giuseppe Fiermonte; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2015-03-11       Impact factor: 4.123

4.  Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia.

Authors:  Giorgia Olivieri; Stefano Pro; Daria Diodato; Matteo Di Capua; Daniela Longo; Diego Martinelli; Enrico Bertini; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2019-08-23       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.